Literature DB >> 28551071

New pathways of treatment for psoriatic arthritis.

Philip Mease1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28551071     DOI： 10.1016/S0140-6736(17)31427-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Lymphocyte mass cytometry identifies a CD3-CD4+ cell subset with a potential role in psoriasis.

Authors:  Ruru Guo; Ting Zhang; Xinyu Meng; Zhen Lin; Jinran Lin; Yu Gong; Xuesong Liu; Yuetian Yu; Guilin Zhao; Xianting Ding; Xiaoxiang Chen; Liangjing Lu
Journal:  JCI Insight       Date:  2019-03-21

2.  Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study.

Authors:  Eleni Kampylafka; Isabelle d'Oliveira; Christina Linz; Veronika Lerchen; Fabian Stemmler; David Simon; Matthias Englbrecht; Michael Sticherling; Jürgen Rech; Arnd Kleyer; Georg Schett; Axel J Hueber
Journal:  Arthritis Res Ther       Date:  2018-07-27       Impact factor: 5.156

3.  Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis.

Authors:  Marco Diani; Fabio Casciano; Laura Marongiu; Matteo Longhi; Andrea Altomare; Paolo D Pigatto; Paola Secchiero; Roberto Gambari; Giuseppe Banfi; Angelo A Manfredi; Gianfranco Altomare; Francesca Granucci; Eva Reali
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.